Back to Journals » Drug Design, Development and Therapy » Volume 16
Original Research
Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
4,671 | Dovepress* | 4,213+ | 90 | 4,303 | |
PubMed Central* | 458 | 209 | 667 | ||
Totals | 4,671 | 299 | 4,970 | ||
*Since 2 December 2022 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed and Google Scholar